ARCHIVES
VOL. 10, ISSUE 2 (2024)
Combating drug-resistant tuberculosis: A case study of successful treatment and the importance of adherence
Authors
Rajendra Tatu Nanavare, Dipak Vinayak Chaudhari, Ashwini Tudme
Abstract
This case study presents a 23-year-old female with cervical
lymphadenopathy, initially treated with anti-tuberculosis medication.
Subsequent histopathological and molecular testing confirmed
multidrug-resistant tuberculosis (MDR-TB) with rifampicin and isoniazid
resistance, as well as resistance to fluoroquinolones, indicating extensive
drug-resistant tuberculosis (XDR-TB). The patient responded well to a tailored
treatment regimen consisting of Bedaquiline, moxifloxacin, linezolid,
clofazimine, and cycloserine, with regression of all lymph nodes observed on
ultrasound monitoring. The case underscores the importance of comprehensive
diagnostics, individualized treatment, and close monitoring in managing
drug-resistant tuberculosis effectively. It emphasizes the need for early
detection, appropriate treatment, and patient adherence to combat
drug-resistant TB and improve outcomes.
Download
Pages:14-16
How to cite this article:
Rajendra Tatu Nanavare, Dipak Vinayak Chaudhari, Ashwini Tudme "Combating drug-resistant tuberculosis: A case study of successful treatment and the importance of adherence". International Journal of Medical and Health Research, Vol 10, Issue 2, 2024, Pages 14-16
Download Author Certificate
Please enter the email address corresponding to this article submission to download your certificate.